BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 8547132)

  • 1. Detection of membrane and soluble interleukin-6 receptor in lymphoid malignancies.
    Lavabre-Bertrand T; Exbrayat C; Liautard J; Gaillard JP; Baskevitch PP; Poujol N; Duperray C; Bourquard P; Brochier J
    Br J Haematol; 1995 Dec; 91(4):871-7. PubMed ID: 8547132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum levels of IL-6 type cytokines and soluble IL-6 receptors in active B-cell chronic lymphocytic leukemia and in cladribine induced remission.
    Robak T; Wierzbowska A; Błasińska-Morawiec M; Korycka A; Błoński JZ
    Mediators Inflamm; 1999; 8(6):277-86. PubMed ID: 10815616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum soluble interleukin-2 receptor levels are associated with clinical disease status and histopathological grade in non-Hodgkin's lymphoma and chronic lymphocytic leukemia.
    Barak V; Ginzburg M; Kalickman I; Polliack A
    Leuk Lymphoma; 1992 Aug; 7(5-6):431-8. PubMed ID: 1493444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-level production of alternatively spliced soluble interleukin-6 receptor in serum of patients with adult T-cell leukaemia/HTLV-I-associated myelopathy.
    Horiuchi S; Ampofo W; Koyanagi Y; Yamashita A; Waki M; Matsumoto A; Yamamoto M; Yamamoto N
    Immunology; 1998 Nov; 95(3):360-9. PubMed ID: 9824498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoassay for functional human soluble interleukin-6 receptor in plasma based on ligand/receptor interactions.
    Montero-Julian FA; Liautard J; Flavetta S; Romagné F; Gaillard JP; Brochier J; Klein B; Brailly H
    J Immunol Methods; 1994 Feb; 169(1):111-21. PubMed ID: 8133069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-6 and soluble IL-6 receptors (sIL-6R and sgp130) in human pleural effusions: massive IL-6 production independently of underlying diseases.
    Doré P; Lelièvre E; Morel F; Brizard A; Fourcin M; Clemént C; Ingrand P; Daneski L; Gascan H; Wijdenes J; Gombert J; Preud'homme JL; Lecron JC
    Clin Exp Immunol; 1997 Jan; 107(1):182-8. PubMed ID: 9010274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of transferrin receptor expression with histologic grade and immunophenotype in chronic lymphocytic leukemia and non-Hodgkin's lymphoma.
    Das Gupta A; Shah VI
    Hematol Pathol; 1990; 4(1):37-41. PubMed ID: 2187855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and activity of the anti-CD79B antibody-drug conjugate polatuzumab vedotin in relapsed or refractory B-cell non-Hodgkin lymphoma and chronic lymphocytic leukaemia: a phase 1 study.
    Palanca-Wessels MC; Czuczman M; Salles G; Assouline S; Sehn LH; Flinn I; Patel MR; Sangha R; Hagenbeek A; Advani R; Tilly H; Casasnovas O; Press OW; Yalamanchili S; Kahn R; Dere RC; Lu D; Jones S; Jones C; Chu YW; Morschhauser F
    Lancet Oncol; 2015 Jun; 16(6):704-15. PubMed ID: 25925619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum levels of soluble IL-6 receptor in multiple myeloma as indicator of disease activity.
    Papadaki H; Kyriakou D; Foudoulakis A; Markidou F; Alexandrakis M; Eliopoulos GD
    Acta Haematol; 1997; 97(4):191-5. PubMed ID: 9158660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum-soluble interleukin-2 receptors in B-cell lymphoproliferative malignancies.
    Pavlidis NA; Manoussakis MN; Germanidis GS; Moutsopoulos HM
    Med Pediatr Oncol; 1992; 20(1):26-31. PubMed ID: 1727208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble interleukin-2 receptor, soluble CD8 and soluble intercellular adhesion molecule-1 levels in hematologic malignancies.
    Srivastava MD; Srivastava A; Srivastava BI
    Leuk Lymphoma; 1994 Jan; 12(3-4):241-51. PubMed ID: 7909467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble IL-6 receptors (sIL-6R) in hematological patients receiving immunotherapy with IL-2/IFN-alpha or donor lymphocytes following bone marrow transplantation.
    Toren A; Novick D; Ackerstein A; Or R; Slavin S; Nagler A
    Bone Marrow Transplant; 1996 Oct; 18(4):721-4. PubMed ID: 8899186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential expression of interleukin-2 receptors (alpha and beta chain) in mature lymphoid neoplasms.
    Nakase K; Kita K; Nasu K; Ueda T; Tanaka I; Shirakawa S; Tsudo M
    Am J Hematol; 1994 Jul; 46(3):179-83. PubMed ID: 7514848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble interleukin 6 receptor in biological fluids from human origin.
    Frieling JT; Sauerwein RW; Wijdenes J; Hendriks T; van der Linden CJ
    Cytokine; 1994 Jul; 6(4):376-81. PubMed ID: 7948745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variable expression of CD49d antigen in B cell chronic lymphocytic leukemia is related to disease stages.
    Eksioğlu-Demiralp E; Alpdoğan O; Aktan M; Firatli T; Oztürk A; Budak T; Bayik M; Akoğlu T
    Leukemia; 1996 Aug; 10(8):1331-9. PubMed ID: 8709639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble interleukin-6 receptor levels in pleural effusions.
    Yokoyama A; Kohno N; Fujino S; Abe M; Ishida O; Hiwada K
    Respir Med; 1996 Jul; 90(6):329-32. PubMed ID: 8759474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble interleukin-6 (IL-6) receptor in the sera of pregnant women forms a complex with IL-6 and augments human chorionic gonadotropin production by normal human trophoblasts through binding to the IL-6 signal transducer.
    Matsuzaki N; Neki R; Sawai K; Shimoya K; Okada T; Sakata M; Saji F; Koishihara Y; Ida N
    J Clin Endocrinol Metab; 1995 Oct; 80(10):2912-7. PubMed ID: 7559874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of interleukin 6 receptor and gp130 expressions and proliferative capability of human CD34+ cells.
    Tajima S; Tsuji K; Ebihara Y; Sui X; Tanaka R; Muraoka K; Yoshida M; Yamada K; Yasukawa K; Taga T; Kishimoto T; Nakahata T
    J Exp Med; 1996 Oct; 184(4):1357-64. PubMed ID: 8879208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble CD23 and other receptors (CD4, CD8, CD25, CD71) in serum of patients with chronic lymphocytic leukemia.
    Beguin Y; Lampertz S; De Groote D; Igot D; Malaise M; Fillet G
    Leukemia; 1993 Dec; 7(12):2019-25. PubMed ID: 8255102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased adiponectin level in non-Hodgkin lymphoma and its relationship with interleukin-10. Correlation with clinical features and outcome.
    Pamuk GE; Turgut B; Demir M; Vural O
    J Exp Clin Cancer Res; 2006 Dec; 25(4):537-41. PubMed ID: 17310845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.